Investigation of Glucose-dependent Insulinotropic Polypeptide (GIP) effects at hyper and hypoglycemia in type 1 diabetes.
Inclusion Criteria:
• Diagnosed with type 1 diabetes (WHO criteria)
Exclusion Criteria:
Hellerup, 2900, Denmark